Business Wire

  1. Valar Labs Announces Strategic Partnership With PathNet Lab To Deliver AI-Driven Bladder Cancer Insights Nationwide 12/22/2025

    Valar Labs, a leader in AI-powered diagnostics for oncology, today announced a strategic partnership with PathNet Lab, one of the nation’s foremost pathology laboratories.

  2. Fulgent Genetics Agrees To Acquire Bako Diagnostics And StrataDx 12/22/2025

    Fulgent Genetics, Inc. (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it has entered into a definitive agreement to acquire selected assets of Bako Diagnostics (“Bako”), a premier pathology laboratory headquartered in Alpharetta, GA and to acquire StrataDx, a premier dermatopathology laboratory located in Lexington, MA.

  3. CellTivity Scientific Receives CE Registration For The Van Gogh Microscopy System, Enabling Real Time Diagnostic Sampling Support Across Europe 12/17/2025

    CellTivity Scientific, a leader in point of care disease detection, today announced that the Van Gogh Microscopy System has received CE registration, enabling clinical use and commercial distribution across the European Union.

  4. Cofactor Genomics Announces Strategic Investment By Labcorp And Ascension Ventures To Fuel Expansion Of Its OncoPrism Immunotherapy Diagnostic Across U.S. Cancer Care Networks 12/15/2025

    Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

  5. Overture Life And CEGYR Establish First Automated Embryology Center Of Excellence To Set Global Benchmark For Reproducible IVF Outcomes Across High-Volume Fertility Networks 12/15/2025

    Overture Life, the global leader in automated IVF and the first company to achieve live births from both robotic fertilization and robotic egg freezing, today announced the establishment of its first Center of Excellence for Automated Embryology in partnership with CEGYR, a flagship fertility program within the Eugin Group.

  6. Sapio Sciences Partners With The Wellcome Sanger Institute On Digital Laboratory Transformation 12/12/2025

    Sapio Sciences, the science-aware AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s ambitious lab transformation program.

  7. Guardant Health And Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service In Italy 12/9/2025

    Guardant Health, Inc., a leading precision oncology company, today announced the successful launch of FPG 360, an in-house liquid biopsy testing service at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Policlinico Gemelli) in Rome, Italy.

  8. Natera Acquires Foresight Diagnostics 12/5/2025

    Natera, Inc., a global leader in cell-free DNA and precision medicine, and Foresight Diagnostics, a leader in ultrasensitive molecular residual disease (MRD) detection, today announced that Natera has completed a transaction to acquire Foresight.

  9. Acupath And Valar Labs Announce Strategic Partnership To Deliver Vesta, AI-Powered Diagnostic Tests For Non–Muscle Invasive Bladder Cancer 12/3/2025

    Acupath Laboratories, a leading provider of subspecialized anatomic pathology services, today announced a strategic partnership with Valar Labs to offer Vesta Bladder, Valar Labs’ AI-powered diagnostic test portfolio, to Acupath’s customers nationwide.

  10. Perspectum And InHealth Announce National Diagnostics Partnership To Boost Oxford CDC Capacity And Widen Access To Advanced MRI Across The UK 12/2/2025

    Perspectum and InHealth have announced a new national diagnostics partnership that will significantly expand access to advanced MRI and increase capacity at the Oxford Community Diagnostic Centre (CDC).